Author： Nawroth Frank Ludwig Michael
Publisher： Reproductive Healthcare Ltd
ISSN： 1472-6483
Source： Reproductive BioMedicine Online, Vol.16, Iss.5, 2008-05, pp. : 621-626
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Liposomal Drug Formulations: Rationale for Development and What We Can Expect for the Future
By Allen T.M.
Drugs, Vol. 56, Iss. 5, 1998-11 ,pp. :
Access to resources
Recommend
The Development Safety Update Report: What can We Expect?
By Davis Brian
Pharmaceutical Medicine, Vol. 23, Iss. 1, 2009-01 ,pp. :
Serotonin Receptors of Type 6 (5-HT6): What can we Expect from them?
Current Medicinal Chemistry, Vol. 18, Iss. 18, 2011-06 ,pp. :
We All Make Mistakes‐But What Can We Do About It?
JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 32, Iss. 4, 2002-12 ,pp. :